Ciprofloxacin/hydrocortisone otic solution

Drug Profile

Ciprofloxacin/hydrocortisone otic solution

Alternative Names: Cipro HC Otic Suspension; Ciproxin HC

Latest Information Update: 27 Aug 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer
  • Class Anti-inflammatories; Antiallergics; Antibacterials; Fluoroquinolones; Glucocorticoids
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Otitis externa

Most Recent Events

  • 26 Aug 2010 Alcon has been acquired by Novartis
  • 28 Jun 2001 ALZA Corporation has been acquired by Johnson & Johnson
  • 14 Nov 2000 ALZA has entered an agreement with Bayer to copromote Cipro® in the US market
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top